VALARTH See Inventurus Knowledge Solutions in the appOpen in app
IKS · NSE · IT Enabled Services

Inventurus Knowledge Solutions Ltd

What the numbers mean, from its filings and the exchange. Data as of 13 Oct 2026.
Small Cap · AMFI list Jan-Jun 2026 · Vendor sector: IT - Software
fair low confidence No valuation within 120 days; P/E 37.6 vs peers 46.9 (4th of 9); P/B 12.7 vs peers 5.6 (9th of 10).
Statements through FY2026Prices adjusted for corporate actionsNot yet reviewed by the adversarial model

What is Inventurus Knowledge Solutions's share price today?

Inventurus Knowledge Solutions last traded at ₹1,717.40 on the NSE, as of 13 Oct 2026, 10:45 am IST, down 0.4% on the day, up 12.5% over a year. Its 52-week range is ₹1,262 to ₹1,970. The live price is in the app.

₹1,717.40 −0.4% today
+12.5% over 1 year · NSE, as of 13 Oct 2026, 10:45 am IST
22 month-end closes, 31 Dec 2024 to 30 Sep 2026, adjusted for splits and bonuses
52-week range64% of the way up
Low ₹1,262High ₹1,970

What is Inventurus Knowledge Solutions's market cap?

Inventurus Knowledge Solutions's market capitalisation is about ₹29,596 crore: what it would cost to buy every share at today's price. That makes it the 46th largest small cap company we cover.

₹29,596 Cr Small Cap46th largest small cap company
Small Cap means the companies ranked 251 and below by size, under SEBI's rules. Shares in issue are worked out from the market cap and the price. What market cap tells you →

Key facts

From the exchange
Symbol
NSE: IKS
ISIN
INE115Q01022
Cap bucket
Small Cap, 46th largest by market cap
Industry (NSE)
Information Technology › IT - Services › IT Enabled Services
Listed since
2024
Futures and options
Not traded

Is Inventurus Knowledge Solutions overvalued?

Fair, with low confidence: no valuation within 120 days; P/E 37.6 vs peers 46.9 (4th of 9); P/B 12.7 vs peers 5.6 (9th of 10).

Valuation

Latest price and trailing 12 months
P/E 37.61
vs peers 46.9 · 4th of 9
Price divided by last year's earnings per share: how many years of today's profit you pay for. Learn more →
P/B 12.68
vs peers 5.6 · 9th of 10
Price divided by book value per share: what you pay for each rupee of net assets on the balance sheet. Learn more →
Market cap ₹29,596 Cr
Total market value of all shares, in ₹ crore. Learn more →
Dividend yield Not available
Last year's dividends as a share of today's price. Learn more →
PEG (vendor) 2.87
vs peers 7.7 · 1st of 6
P/E divided by the vendor's earnings growth figure, which it does not disclose; a P/E adjusted for how fast profits grow. Learn more →
PEG on our 3-year EPS growth 1.14
P/E divided by the 3-year EPS growth rate from the stored accounts. Learn more →
2 models could be judged
Skipped — Fair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored; P/E vs own history: 0 of 36 months of P/E history

Our valuation range

🔒 Pro
Value range, implied growth at today's price, and the nine models behind it: in the app.

Is Inventurus Knowledge Solutions a quality business?

Quality score 62, 2nd of 11 in its peer set; WATCH on 26 of 30 flags judged.

Quality and risk

Data as of 13 Oct 2026
Business quality Not available
The kind of business, which sets the yardstick it is judged by. Learn more →
Quality score 62
vs peers 52.5 · 2nd of 11
Returns, margins, leverage and consistency against its peers, out of 100. Learn more →
Risk level WATCH
26 of 30 flags judged
From flags on debt, earnings quality, dilution and price swings. Learn more →

Profitability

ROE 37.6%
vs peers 6.7% · 1st of 11
Return on equity: profit as a share of shareholders' money. Learn more →
ROCE 43.6%
vs peers 12.0% · 1st of 11
Return on capital employed: operating profit as a share of all the capital in the business, debt and equity. Learn more →
Profit margin 22.7%
vs peers 9.3% · 1st of 9
Profit after everything, as a share of revenue. Learn more →
EPS ₹42.27
Trailing 12 months
Profit for each share over the last 12 months.

Scorecard

🔒 Pro
Health scores and red flags with their values and history: in the app.
Inside the app

Get a sneak peek of Valarth

Start freeStart free
A Valarth stock page: the share price with its chart and 52-week range, valuation and profitability figures, and a scorecard of health checks.
Stock pagePrice, valuation, profitability and a scorecard of health checks for every company, each figure explained.
The Valarth stock screener: a table of companies with price, market cap, P/E, P/B, PEG, EPS and ROE, and filters down the left.
ScreenerEvery listed company, filtered on 212 figures, each with a plain-language lesson beside it.
The Valarth AI Screener answering 'Which companies will benefit from India's Project 75 submarine programme?' with a basket of four naval shipbuilders and a written thesis.
AI ScreenerAsk a question in plain English, like which companies benefit from India's Project 75. It reads the intent, builds the screen and writes the thesis.
A Valarth business-model card for State Bank of India, with a plain-language summary and statements verified against the filing.
Business modelHow a company makes money and what can hurt it, each statement checked against its annual report.
Valarth's Before the Bell edition, with the day's headline, regulator notes and sector moves.
Before the BellA morning edition before the market opens: what moved, which rule changed, and what it means for your holdings.

Has Inventurus Knowledge Solutions made money for shareholders?

Yes: +12.5% over one year.

Shareholder returns

1-year return +12.5%
Price only
What the share price did over the last 12 months. Learn more →
5-year return Not available
Yearly average price return over five years, bonuses and splits adjusted. Learn more →
Wealth destroyer Not available
Five-year total return — price CAGR on bonus- and split-adjusted closes plus the dividend yield — below the 7% a bank fixed deposit paid. Learn more →

Returns

3Y and 5Y are yearly averages
1W
−2.1%
1M
−3.3%
3M
−9.4%
6M
+13.9%
1Y
+12.5%
3Y
—
5Y
—
— not available

Is Inventurus Knowledge Solutions growing?

Revenue 3 years 44.7% a year; profit 3 years 33.2% a year; revenue 5 years 33.8% a year.

Growth

Statements through FY2026 (Mar-26)
Revenue 3 years 44.7% a year
vs peers 21.6% · 3rd of 11
Compound annual growth of revenue over three years. Learn more →
Profit 3 years 33.2% a year
vs peers 23.0% · 4th of 8
Compound annual growth of net profit over three years. Learn more →
Revenue 5 years 33.8% a year
Compound annual growth of revenue over five years. Learn more →
Profit 5 years 26.8% a year
Compound annual growth of net profit over five years. Learn more →
EPS 3 years 33.1% a year
Growth in earnings per share, so dilution counts against the company. Learn more →
EPS 5 years 32.9% a year
Growth in earnings per share over five years, so dilution counts against the company. Learn more →
P/E vs own history Not available
Today's P/E against its own 5-year median; negative is cheaper than its history. Learn more →

How did Inventurus Knowledge Solutions do last quarter?

Inventurus Knowledge Solutions reported revenue of ₹894 Cr, up 19.9% on a year earlier and a net profit of ₹194 Cr, up 48.5% in the Jun 2026 quarter.

Latest quarter

Jun 2026
Revenue, latest quarter₹894 Cr
+19.9% on a year earlier
What the company took in over the quarter.
Net profit, latest quarter₹194 Cr
+48.5% on a year earlier
What was left for shareholders after every cost and tax.

How does Inventurus Knowledge Solutions compare with its peers?

Compared with 10 IT Enabled Services; 4th of 9 on P/E; 2nd of 11 on quality score.

Compared with 10 IT Enabled Services

10 companies

Inventurus Knowledge Solutions against its peers

Largest 10 of 10 peers, by market cap
CompanyMarket capP/EP/BROEROCE1YQuality 🔒Rank 🔒
Inventurus Knowledge Solutions Ltd₹29,596 Cr37.612.737.6%43.6%+12.5%
L&T Technology Services Ltd₹35,104 Cr26.35.620.7%25.7%−21.1%
Netweb Technologies India Ltd₹29,730 Cr102.924.432.9%37.3%+28.6%
Tata Technologies Ltd₹29,083 Cr52.211.733.3%36.1%+2.2%
Sagility Ltd₹20,219 Cr20.81.83.4%4.7%−6.6%
Affle 3i Ltd₹20,054 Cr41.79.85.5%8.1%−27.2%
ESDS Software Solution Ltd₹18,415 Cr——17.6%20.4%+73.0%
Black Box Ltd₹16,421 Cr64.011.33.8%4.3%+61.0%
E2E Networks Ltd₹15,120 Cr—2.5-0.9%-0.5%+122.9%
Cyient Ltd₹12,826 Cr33.82.38.0%15.9%−0.8%
Amagi Media Labs Ltd₹12,498 Cr119.84.31.5%1.3%+63.0%
Peer median—46.95.66.7%12.0%+11.8%
Market cap in rupees crore; P/E and P/B on the latest price; 1Y is the price return over a year. A dash is a figure that does not apply or is not reported.

Full peer comparison

🔒 Pro
Every peer, every figure, the ranks and the quality and forensic scores side by side: in the app.

Who owns Inventurus Knowledge Solutions?

Inventurus Knowledge Solutions is held by promoters 63.7%, foreign institutions 8.0%, domestic institutions 7.5%.

Shareholding pattern

Latest filing, percent of shares
Promoters63.7%
The founders and controlling group.
Foreign institutions8.0%
Overseas funds investing through the FPI route.
Domestic institutions7.5%
Indian insurers, banks, pension and mutual funds together.
Mutual funds2.9%
Indian mutual fund schemes; part of domestic institutions.
Retail and others5.7%
Individual investors and everyone else.
Promoter shares pledged🔒 In the app
Promoter shares given as collateral for loans; a high share is a risk to watch.
Holding trend🔒 In the app
Whether promoters, foreign funds and mutual funds have been adding or selling over recent quarters.

What do analysts say about Inventurus Knowledge Solutions?

8 analysts cover Inventurus Knowledge Solutions, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.

Analyst consensus

8 analysts
ConsensusBuy
The rating most covering analysts give the share.
Average target price🔒 In the app
The mean of the analysts' 12-month price targets.
Upside to target🔒 In the app
How far the target sits above or below today's price.
Share rating it a buy🔒 In the app
The share of covering analysts with a buy rating.

What does Inventurus Knowledge Solutions do and what is it sensitive to?

Inventurus Knowledge Solutions Limited (IKS Health) provides a tech-enabled healthcare provider enablement platform to US-based healthcare organizations, including services that help hospitals manage collections from insurance companies and manage physicians' clinical workflow. Sensitive to: US dollar against Indian rupee.

Business-model card

FY2025 · 38 verified
4Revenue
3Channels
1Regulators
3Reg. dependencies
4Sensitivities
4Costs
3Geographies

Inventurus Knowledge Solutions Limited (IKS Health) provides a tech-enabled healthcare provider enablement platform to US-based healthcare organizations, including services that help hospitals manage collections from insurance companies and manage physicians' clinical workflow. It earns through SOW-based services fees and software licences, with billing that can vary by per-person-per-month fee, percentage of net collections, or per-customer-per-month.

Revenue engine

4 verified
Revenue recognised at a point in time
Standalone FY2025 revenue of 8,952.14 (of 9,730.83 total) recognised when the performance obligation is completed. Interpretation: term software licences are recognised at a point in time when the licence is granted (see chunk 42).
Revenue recognised over a period of time
Standalone FY2025 revenue of 778.69 recognised as services are provided under the SOWs. Interpretation: time-and-material services are recognised over the period in which they are performed.
Revenue-cycle collection services for hospitals
Company assists healthcare providers such as hospitals to manage collections from insurance companies, billed under each SOW. Interpretation: fees can be tied to collections performance.
1 more statement
Software licensing to healthcare customers
Company also licenses software to customers, sometimes bundled with services in one contract, with performance obligations split out.

Customers & channels

3 verified
Customers individually above 10% of revenue
Standalone FY2025: 3 customers each above 10% of total revenue, totalling 4,583.56. Interpretation: concentration is high relative to total standalone revenue of 9,730.83.
Well-established hospitals and health systems as clients
Receivables are concentrated in healthcare, and clients are typically established hospitals, medical facilities or major health systems. Interpretation: credit exposure follows the financial health of these providers.
Physician enterprises consolidating under hospitals, health systems and corporate owners
Company states that consolidation creates growing non-clinical tasks that it takes over for healthcare delivery enterprises. Interpretation: consolidated owners are a buyer group for outsourced chores.

Regulators

1 verified
Foreign Exchange Management Act, 1999 (FEMA)
Governs the company's Foreign Direct Investment, Overseas Direct Investment and External Commercial Borrowings, which affect how it is capitalised and funded.

Regulatory dependencies

3 verified
Changes in healthcare regulations and reimbursement models
Frequent changes require ongoing adaptation; non-compliance can bring penalties or operational disruption. Interpretation: a change in reimbursement structure can alter client demand for the company's billing and workflow services.
Shift to value-based reimbursement
Providers must adapt to new care models and reimbursement structures. Interpretation: changes in payment structure can change which services clients buy and how they are priced.
Privacy laws governing healthcare data
Handling sensitive healthcare data exposes the company to breaches and evolving privacy regulations. Interpretation: stricter privacy rules raise compliance cost and penalty exposure.

Sensitivities

4 verified
US dollar against Indian rupee
Per the consolidated sensitivity, a 5% strengthening of USD reduces FY2025 profit after tax by 52.75 and a 5% weakening increases it by 52.75. Interpretation: rupee strength against USD lowers reported profit.
Interest rates on variable-rate borrowings
Company states a 100 basis point change would have an insignificant impact on profit or loss. Interpretation: borrowing-cost exposure is small in the reported sensitivity.
Healthcare sector and US geographic concentration
Company states it is subject to sector and geographic concentration as its entire operation is in the United states. Interpretation: US healthcare spending and provider demand drive the whole revenue base.
1 more statement
Client payment timing
Payments from clients have been received generally within normal time frames for the industry. Interpretation: receivable collection delays would hit working capital.

Cost inputs

4 verified
Employee benefit expenses (56.1%)
Largest cost line, 14,946.06 in FY2025 (56.10% of revenue), driven by the full-year Aquity acquisition and expansion of sales and technology teams.
Global human capital and pragmatic technology
Company states it delivers through a blend of pragmatic technology and global human capital. Interpretation: staff, including offshore talent, is the main delivery input.
Research and development spend
Company invests in R&D to strengthen technology leadership; R&D expenditure 1,181.54 million in FY25. Interpretation: R&D is a recurring cost line that funds platform development.
1 more statement
Borrowings
Term loan at weighted average 7.80% in FY2025 on 7,207.72 balance (standalone, chunk 49 consolidated shown). Interpretation: borrowing cost is a finance cost input.

Geographies

3 verified
United States (95.8%)
Revenue from US healthcare organizations is the core market; the entire business operation is in the United states.
Revenue from customers outside India
Consolidated revenue from external customers is wholly derived from customers located outside India.
Offices across India, US, Canada and Australia
Company states it has offices globally across 4 countries and 3 continents, with delivery teams in India and the US.
Each statement is checked word for word against the FY2025 annual report; the passages are in the app.

What changed recently?

Q1 FY2027 results filed (5 Aug 2026).

Change log

6 entries · newest first
  1. Results filedQ1 FY2027 results filed.
  2. Results filedQ4 FY2026 results filed.
  3. Results filedQ3 FY2026 results filed.
  4. Results filedQ2 FY2026 results filed.
  5. Results filedQ1 FY2026 results filed.
  6. Results filedQ4 FY2025 results filed.
Get alerts →Sign in to be told when any of these change.

What this page does not tell you

What could not be judged, and why. Never empty.
  • Models not runFair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored; P/E vs own history: 0 of 36 months of P/E history.
  • FlagsWATCH on 26 of 30 flags judged; 1 red; 4 could not be judged.
  • Data gapsDividend yield, Business quality, 5-year return, Wealth destroyer, P/E vs own history: not available yet.
Not applicable to this company · 1
  • Altman ZAltman Z is a manufacturing model; a service business has no inventory or plant turnover for it to read.

What this page rests on

✓7 years of annual statements, through FY2026 (Mar-26)✓10 quarters of results✓22 months of month-end prices, adjusted for bonuses and splits○no valuation of ours yet✓business-model card FY2025 · 38 verified

Questions people ask

What is Inventurus Knowledge Solutions's share price today?

Inventurus Knowledge Solutions last traded at ₹1,717.40 on the NSE, as of 13 Oct 2026, 10:45 am IST, down 0.4% on the day, up 12.5% over a year. Its 52-week range is ₹1,262 to ₹1,970. The live price is in the app.

What is Inventurus Knowledge Solutions's market cap?

Inventurus Knowledge Solutions's market capitalisation is about ₹29,596 crore: what it would cost to buy every share at today's price. That makes it the 46th largest small cap company we cover.

Is Inventurus Knowledge Solutions Ltd a large cap, mid cap or small cap?

Inventurus Knowledge Solutions Ltd (IKS) is a small cap company in AMFI's classification for Jan-Jun 2026. SEBI's buckets go by rank on six-month average market capitalisation: the top 100 are large caps, 101 to 250 mid caps, the rest small caps.

What is Inventurus Knowledge Solutions Ltd's P/E ratio?

37.61, vs peers 46.9 · 4th of 9. Price divided by last year's earnings per share: how many years of today's profit you pay for.

Is Inventurus Knowledge Solutions Ltd overvalued?

Fair, with low confidence: no valuation within 120 days; P/E 37.6 vs peers 46.9 (4th of 9); P/B 12.7 vs peers 5.6 (9th of 10).

How does Inventurus Knowledge Solutions Ltd make money?

Inventurus Knowledge Solutions Limited (IKS Health) provides a tech-enabled healthcare provider enablement platform to US-based healthcare organizations, including services that help hospitals manage collections from insurance companies and manage physicians' clinical workflow. It earns through SOW-based services fees and software licences, with billing that can vary by per-person-per-month fee, percentage of net collections, or per-customer-per-month.

Who are Inventurus Knowledge Solutions Ltd's peers?

Compared with 10 IT Enabled Services: L&T Technology Services Ltd, Netweb Technologies India Ltd, Tata Technologies Ltd, Sagility Ltd, Affle 3i Ltd and 5 more. The app shows how they compare on every figure.

Is this investment advice?

No. Valarth is a research and learning tool and is not a SEBI-registered investment adviser or research analyst. The figures come from the company's filings and the exchanges; what to do with them is your call.

How did Inventurus Knowledge Solutions do last quarter?

Inventurus Knowledge Solutions reported revenue of ₹894 Cr, up 19.9% on a year earlier and a net profit of ₹194 Cr, up 48.5% in the Jun 2026 quarter.

Who owns Inventurus Knowledge Solutions?

Inventurus Knowledge Solutions is held by promoters 63.7%, foreign institutions 8.0%, domestic institutions 7.5%.

What do analysts say about Inventurus Knowledge Solutions?

8 analysts cover Inventurus Knowledge Solutions, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.

More small cap companies

Everything on Inventurus Knowledge Solutions, and 6,621 other companies, with 212 filters and the full peer tables